Not Tagged
roche
['dlbcl', 'genentech']
#breaking: today at #ash22, we re presenting new, updated phase iii data of a treatment regimen with the potential to improve multiple outcomes for people with previously untreated #dlbcl, an aggressive type of blood cancer. learn more: 
Official Twitter for Genentech. See our community guidelines here: https://t.co/yas51FOJVm